ADVERTISEMENT

Conference Report

ERS 2022 — Antibiotics a ‘no-no’ in early-life severe respiratory syncytial virus bronchiolitis

Shrabasti Bhattacharya   |   09 September 2022

Takeaway

  • In infants with early-life severe respiratory syncytial virus (RSV) bronchiolitis, a 14-day treatment with azithromycin did not lower the risk for recurrent wheezing over the following 2-4 years.
  • The risk for recurrent wheezing was higher with azithromycin versus placebo when the participants did not receive any other antibiotic.
  • The use...

          

November Challenge

Ends in 1d 7h
left
right

Topic Challenges

left
right